Generic Name and Formulations:
Tropicamide 0.5%, 1%; oph soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for MYDRIACYL:
For mydriasis and cycloplegia for diagnostic procedures.
Adults and Children:
For refraction: instill 1–2 drops of 1% soln in the eye(s); repeated in 5 minutes. An additional drop may be instilled if patient is not seen within 20–30 minutes. For examination of fundus: instill 1–2 drops of 0.5% soln 15 or 20 minutes prior to exam. Lacrimal sac should be compressed by digital pressure for 2–3 minutes after instillation to reduce excessive systemic absorption.
Remove contact lenses before use. Pregnancy (Cat.C). Nursing mothers.
May interfere with antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.
Ocular (eg, stinging, blurred vision, photophobia, superficial punctuate keratitis, transient elevation of intraocular pressure), dry mouth, tachycardia, headache, allergic reactions, GI upset, pallor, CNS disturbances (esp. in children).
Soln 0.5%—15mL; 1%—3mL, 15mL
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Adverse Events Caused by Once-Monthly Aripiprazole Are Time Limited
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses